# Primary Prevention of Stroke in Children With SCD in Sub-Saharan Africa II

Study · id `cardio:ct-nct02560935` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02560935](<https://clinicaltrials.gov/study/NCT02560935>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02560935

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 440 participants.

## Technical summary

Registry record NCT02560935. Randomized; double masking; primary purpose prevention. Start 2016-07-19 (actual); primary completion 2020-03-03 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; double masking; primary purpose prevention
- Phase: Phase 3
- Enrolled: 440 participants (enrolled count; ClinicalTrials.gov record NCT02560935, source copy `cardio:ctgov-nct02560935-2020-08-03`, retrieved 2026-10-26)
- Started: 2016-07-19 (actual) (ClinicalTrials.gov record NCT02560935, source copy `cardio:ctgov-nct02560935-2020-08-03`, retrieved 2026-10-26)
- Primary completion: 2020-03-03 (actual) (ClinicalTrials.gov record NCT02560935, source copy `cardio:ctgov-nct02560935-2020-08-03`, retrieved 2026-10-26)
- Completion: 2020-03-03 (actual) (ClinicalTrials.gov record NCT02560935, source copy `cardio:ctgov-nct02560935-2020-08-03`, retrieved 2026-10-26)
- Countries: Nigeria (ClinicalTrials.gov record NCT02560935, source copy `cardio:ctgov-nct02560935-2020-08-03`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02560935-2020-08-03`, retrieved 2026-10-26)

## The registry's words

- Brief title: Primary Prevention of Stroke in Children With SCD in Sub-Saharan Africa II
- Acronym: SPRING
- Condition: Sickle Cell Disease
- Condition: Stroke
- Intervention (Drug): Hydroxyurea (Moderate Dose)
- Intervention (Drug): Hydroxyurea (Low Dose)
- Lead sponsor: Vanderbilt University Medical Center
- Lead sponsor class: OTHER
- Collaborator: Aminu Kano Teaching Hospital
- Collaborator class: OTHER
- Collaborator: Murtala Muhammed Specialist Hospital
- Collaborator class: OTHER
- Collaborator: National Institute of Neurological Disorders and Stroke (NINDS)
- Collaborator class: NIH
- Collaborator: Barau Dikko Teaching Hospital/Kaduna State University
- Collaborator class: UNKNOWN

## Connected pages

- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry lists this organization as the lead sponsor: Vanderbilt University Medical Center (`cardio:org-vanderbilt-university-medical-center`)
- Registry lists this organization as a collaborator: Aminu Kano Teaching Hospital (`cardio:org-aminu-kano-teaching-hospital`)
- Registry lists this organization as a collaborator: Murtala Muhammed Specialist Hospital (`cardio:org-murtala-muhammed-specialist-hospital`)
- Registry lists this organization as a collaborator: National Institute of Neurological Disorders and Stroke (`cardio:ninds`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Hydroxyurea for primary stroke prevention in children with sickle cell anaemia in Nigeria (SPRING): a double-blind, multicentre, randomised, phase 3 trial (`cardio:pubmed-34971579`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Underweight children older than 5 years with sickle cell anemia are at risk for early mortality in a low-resource setting (`cardio:pubmed-36383708`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: c6833fcc887f47aafb68cb209a6929a1d36434c785caf6961488fb7a6a2a188a
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
